Bioleaders Corporation (142760) — Cash Flow Reinvestment Rate
Bioleaders Corporation (142760) has a Cash Flow Reinvestment Rate of 76.60x as of September 2024, reinvesting ₩3.80 Billion (capex ₩1.04 Billion plus investments ₩2.75 Billion) from operating cash flow of ₩49.56 Million. Check Bioleaders Corporation cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bioleaders Corporation Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Bioleaders Corporation across 1 annual periods. Explore Bioleaders Corporation long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Bioleaders Corporation (2023–2023)
Year-by-year capital reinvestment analysis for Bioleaders Corporation. For live market cap and broader valuation context, see 142760 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.01x | ₩30.93 Billion | ₩6.18 Billion | ₩378.81 Million | — |